Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis NEULANDLAB

Max Ratio

1.83

Dividend Yield

0.15 %

5Y Dividend Growth

1 067.00 %

Consecutive Years

3 years

5Y Average Payout Ratio

12.06 %

Dividend History NEULANDLAB

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 0.15 %
Consecutive Years 3
Forward Annual Dividend 26.00 INR
Consistent Years 3
Dividend CAGR 3Y 67.11 %
Continuous Dividends
Dividend CAGR 5Y 63.45 %
Payout Ratio TTM 6.41 %
Dividend CAGR 10Y 25.60 %
Ex Dividend Date 07/18/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth NEULANDLAB

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin NEULANDLAB

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income NEULANDLAB

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM NEULANDLAB

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio NEULANDLAB

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Neuland Laboratories Limited NEULANDLAB

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself NEULANDLAB

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 91.02
Forward PE 18.45
Enterprise Value Revenue 14.66
Price Sales TTM 14.24
Enterprise Value EBITDA 54.37
Price Book MRQ 13.44

Neuland Laboratories Limited Dividends: 0.071 % Yield, History, Payment Schedule

NEULANDLAB
Current price
16 887.00 INR -108.14 INR (-0.64%)
Last closed 16 995.00 INR
ISIN INE794A01010
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange National Stock Exchange of India
Capitalization 218 311 737 789 INR
Yield for 12 month -4.03 %
1Y
3Y
5Y
10Y
15Y
NEULANDLAB
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+14 769 570 149 INR

Last Year

+15 587 068 438 INR

Current Quarter

+5 143 147 857 INR

Last Quarter

+2 927 764 345 INR

Current Year

+7 263 881 789 INR

Last Year

+8 248 506 558 INR

Current Quarter

+2 847 309 795 INR

Last Quarter

+1 398 453 359 INR
EBITDA 3 288 042 533 INR
Operating Margin TTM 25.86 %
Price to Earnings 91.02
Return On Assets TTM 7.23 %
PEG Ratio
Return On Equity TTM 15.93 %
Wall Street Target Price 1 878 554.33 INR
Revenue TTM 15 335 418 748 INR
Book Value 1 262.89 INR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 65.40 %
Dividend Yield 0.15 %
Gross Profit TTM 7 732 814 939 INR
Earnings per share 186.73 INR
Diluted Eps TTM 186.73 INR
Most Recent Quarter III 2025
Quarterly Earnings Growth YOY 194.90 %
Profit Margin 15.66 %

Technical Indicators NEULANDLAB

For 52 Weeks

10 183.09 INR 19 748.60 INR
50 Day MA 16 367.71 INR
Shares Short Prior Month
200 Day MA 13 586.50 INR
Short Ratio
Shares Short
Short Percent